1475
PŘEHLEDOVÉ479422701004388130181216258306358404446
ČLÁNKY525622701003973122176223272
Potenciální163833701004079105140178209224259274312327
využití198133701003574112144159186202
laboratorního22003370100144987126151186212251275314329368407
monitorování262333701005998136152178217241280316351389404
při30433370100376279
individualizaci31383370100145290105142158196234268284299331366397412
dávkování356633701003772107142180216251289304
přímých38863370100386278138174204242
perorálních41443370100377397135160195211248264294331
antikoagulancií44923370100337198114148186221260297313347385416431446
–4954337010038
přehled50083370100386297135150186224
literatury5248337010015305792116152178217241279
|5584227010018
451564222701004174102
/35788043010732
Vnitř3655804301074592111139166
Lék.3840804301074184122140
2023;69(7):438-4514000804301074487128172186231274298341366380423465508536583624663
/47088043010732
VNITŘNÍ48058043010746106127172221280301
LÉKAŘSTVÍ5128804301074084130188235279325377399
www.casopisvnitrnilekarstvi.cz42580430107651332012142542953293774274464795215705896176436927117307748128548809159449871007102310631101
21.425553085367082
Gosselin5245540834482109136171186201239
RC,780554083367790
Adcock8875540834179111148181211
DM,111555408346101114
Bates1246554083366990124151
SM,14145540833387101
et15325540833456
al.1606554083314760
International1683554083155374108129168200222237275314346361
Council20625540833976115153185200215
for2294554083195678
Standardization2389554083335487125164196217255270299333355370408446
in28535540831452
Haematology4256540834476111169202223260276314354386
(ICSH)828654083183374108152171
Recommendations10166540833570103140198256291329368400422437475514540
for1573654083185678
Laboratory16686540833164104143164197219256277311
Measurement19966540835590122148186207241299334372393
of24066540833857
Direct2480654083456182116148173
Oral26706540834768101117
Anticoagulants.28046540834179425754083223769106139178215231263301323350364
Thromb804754083337293130189228
Haemost.10477540834477112169208234258271
2018;118(3):437-450.13337540833469100131143174201232251285302314348381413432468501535548
22.425853085367288
Wright533854083577893132170192
C,7458540834052
Brown817854083365794145184
R,10218540833549
Cuker10908540834076107141162
A.12728540834155
Laboratory13478540833265104143165198220256278312
measurement16798540835792124151188209243301336374396
of20958540833756
the2171854083226095
direct2286854083385374108141165
oral2471854083375992107
anticoagulants:2598854083327091107139175208248285425954083154785106134146
Indications584954083155392107139172193209246285311
and9089540833270109
impact10299540831573112145177201
on12439540833775
management13319540835790128160199234291326364386
in17309540831452
clinical179595408331466199114146179194
practice.2002954083396093125149164196230242
Int2257954083155374
J234495408324
Lab23819540833165104
Hemato.l24989540834479136169190227240256
2017;2767954083346899129138
3942510540833467
Suppl50810540833270109148164
1:31-36.6881054083344277108127159194207
23.4251153085367287
Douxfils53211540834584122153173190205231
J,78211540832436
Adcock83711540834179112149181211
DM,1067115408346101114
Bates12001154083356890124151
SM,137011540833287100
et148911540833456
al.15641154083324760
2021164311540833569101133
Update179511540834483122154176210
of202411540833756
the20991154083226095
International22131154083155374108129168200222237275314346362
Council259411540833976115153185200215
for28281154083185678
Standardization4251254083325486124163196217255270299333355370408446
in88812540831552
Haematology95712540834477111169202223260276314354386
Recommendations136012540833570103140198256291329368400422437475514540
for19171254083185677
Laboratory201112540833165104143164197219256278312
Measurement233912540835590122148185207241299334372393
of274912540833756
Direct2822125408345614251354083215587112
Oral55213540834769102117
Anticoagulants.68413540834179101116148185218257295310342380402430443
Thromb11431354083327192130188227
Haemost.138613540834476111169207234257270
2021;121(8):1008-1020.167213540833468101132140171200232247281299311340372408443466497528561595608
24.4251453085367288
Penka53414540833670108139173
M,72814540835569
Novotný81814540834584117155178217248
J.108714540832437
Co114514540834078
lze12441454083154579
očekávat134414540833871105136171203236258
od162314540833878
monitoringu172214540835897137152175213235251289329367
DOACs.211014540834695136176204218
Interv23491454083155375110132167
Akut253714540834172111134
Kardiol.26921454083357091130146184201214
2020;19(4):215-221.42515540833468101135148178208228260278290325356386408439474506515
25.4251653085367287
Edwina52716540833371122138176208
AE,7491654083417488
Dia8511654083456193
N,95816540834558
Dreesen103016540834667101137164199237
E,128116540833346
et134216540833356
al.14121654083324760
Insights1487165408315537994133171192220
into17211654083155374111
the18471654083216095
Pharmacokinetics195616540833573105126184217249286317333371406428443475503
and247416540833169108
Pharmacodynamics25971654083357210512618421724928642517540833870109141199214246274
of71417540833756
Direct7861754083456182116148172
Oral97417540834768101117
Anticoagulants110617540834179101116148185218257295310342380402429
in155117540831452
Older161817540834763102137158
Adults179217540834079116132154182
with19891754083516689127
Atrial2131175408341628499131147
Fibrillation:22931754083324786108123138154186208223261299311
A2620175408341
Structured267617540833253751131451692074251854083215594
Narrative5351854083447798120153174190222256
Review.80718540833570102118153204215
Clin10371854083405570108
Pharmacokinet.116018540833673105126185217249286317333371406428442
2023;62(3):351-373.161718540833468101136147183217234268285297332365396414447479513526
26.4251953085367187
Liu5291954083314784
Z,63019540833851
Xie6981954083385388
Q,80319540834760
Xiang8801954083395486124163
Q,106019540834760
et113719540833456
al.12101954083324760
Anti‑FXa‑IIa128719540834179101116139173212244267283298331
activity16351954083326488103136151174208
test18601954083215582105
in198219540831552
Asian20511954083416984116154
and222219540833270109
its23481954083143765
potential242919540833978100134172193209240256
role27021954083205874108
for28271954083195678
drug4252054083385996135
adherence57220540833270108142163197234266299
evaluation8842054083336597112149181203218255293
in118920540831552
patients12542054083387192107141179200227
with14942054083506587125
direct16312054083385373107139163
oral18062054083375891106
anticoagulants:19242054083326991106137173206244282297328366387414426
a2363205408331
nationwide24072054083376990105143180230246284318
multi­273820540835794109131146167
‑center4252154083215588126148182203
synchronization6432154083265998130168189226265280309342364379417456
study.11142154083264987126158168
Cardiovasc12982154083397293132147185217250276308
Diagn16222154083456193132170
Ther.180721540833372107128138
2020;10(5):1293-1302.196121540833468101135148178209229262281293323352387419441472502536569582
27.4252253085367180
Alalawneh5212254083415689104136187226261299
M,83622540835568
Awaisu92122540834191123139165202
A,113922540834155
Rachid121122540833568100138153192
O.142022540834758
Rivaroxaban14952254083355183116137175205238277310348
Pharmacokinetics185922540833673105126185217249286317333371406428444476503
in237922540831552
Obese244822540834787122149184
Subjects:264922540833269109124159192216243256
A425235408341
Systematic4812354083336390113146204237258274306
Review.80223540833570103118153204215
Clin10322354083405670108
Pharmacokinet.115623540833572105126184216249286316333370405428441
2022;61(12):1677-1695.161223540833569102136149184215230261291309321351382415449468499530564598610
28.4252453085377795
Gregorová56824540834570107150192217258293329
J,94524540832540
Tašková10322454083346595128169205241
I,132024540831631
et139924540833560
al.15072454083335167
Antikoagulační162124540834284109127160201238280322340375411452470
terapie.21392454083225984120163181220235
Maxdorf.242124540835692127169211235260274
2022.274324540833572109147162
ISBN4252554083154782127
978-80-7345-728-0.56825540833467100123159194218249283319352374405439473496533545
29.4252653085367285
Moner‑Banet52526540835493131166188207244277315350373
T,91226540833241
Alberio9672654083415796131153168206
L,118726540833245
Bart12472654083356889114
PA.13752654083357287
Does147626540834684120147
One163726540834786121
Dose177226540834584110145
Really193226540833570102117132164
Fit21102654083334870
All?2194265408341577298
On230626540834786
the24062654083226095
Monitoring251526540835493131146169206227243281320
of284926540833757
Direct4252754083445979112144167
Oral6042754083466798113
Anticoagulants:7292754083407797112143178210248284299330367387414426
A1167275408340
Review121827540833569100115148198
of142827540833655
the14942754083225892
Literature.1598275408331456799120152172209229262274
Hamostaseologie.188327540834475131168194216248273307345360397435449483494
2020;40(2):184-200.23892754083336698131143177211230263280291320350385407437470505516
30.4252853085367287
Patel5282854083356789122138
JP,6822854083246064
Byrne7612854083366890128163
RA,9402854083357892
Patel10482854083356788122138
RK,12012854083367186
et130328540833456
al.13742854083324760
Progress14502854083355693132153188214241
in170628540831553
the17742854083226095
monitoring188428540835896135150172209231246284323
of222328540833756
direct22952854083385374108141165
oral24752854083375992107
anticoagulant259828540833270911061381752082472854252954083154785107
therapy.5472954083226095116149188219229
Br79229540833556
J864295408324
Haematol.90329540834477112170202224261276289
2019;184(6):912-924.120829540833468100130143173204240260293311323358390420440475508540553
31.4253053085366981
Rottenstreich5193054083357395119152190216239260294309341378
A,91030540834155
Zacks97730540833871103132161
N,115130540834457
Kleinstern12213054083345185100138164187220241280
G,151330540834457
et158330540833355
al.16513054083324760
Direct‑acting17233054083456182115148172192224255279294332371
oral21063054083375992107
anticoagulant22253054083327091106138174207246283298330368389
drug26273054083385997135
level27753054083154981115131
monitoring42531540835796134149172209230246284323
in76331540831553
clinical831315408331466199114146179195
patient10413154083397193109143181203
management.125931540835890128160199234292327365387400
J1674315408325
Thromb17143154083327293130188227
Thrombolysis.19573154083327293130188227266282314341356382396
2018;45(4):543-549.236831540833468100131143178211228261279291326361394416449485518529
32.4253253085367186
Šinigoj5293254083324785100139177192
P,73932540833540
Malmström79732540835487102160186209231268326
RE,11413254083356982
Vene124132540833568106141
N1400325408345
et146332540833456
al.15373254083314760
Dabigatran161432540834678117133172204226247280318
Concentration:195032540834077115147181219241262295317332370409421
Variability23893254083356688103135174190205220243276
and268332540833270109
Potential2810325408335714253354083225593115130162178
Bleeding6213354083365186122161176214253
Prediction8933354083355590129144176200216254292
In120433540831452
„Real‑Life“12753354083205792124140162195210230264285
Patients15793354083356789104139177198226
With18243354083577396134
Atrial19763354083416284100132147
Fibrillation.21413354083334887108124139154187208224262300313
Basic24733354083356895109141
Clin26333354083405570108
Pharmacol27593354083367310512642534540835790122159175
Toxicol.6153454083336797112144181197210
2015;117(5):323-329.84034540833569100130141171199228245278297309344376411433465498532543
33.4253553085367085
Skeppholm5223554083326195134172210248263320
M,85435540835467
Hjemdahl9343554083435892149188219257272
P,121835540833539
Antovic126935540834178100136167183214
JP,14953554083245964
et157135540833355
al.16393554083314658
On171035540834684
the18073554083215993
monitoring191235540835795132147169205226242279317
of224135540833756
dabigatran230935540833870108123162193215236268305
treatment26273554083214275107128185220257278
in42536540831553
„real4933654083204276108124
life“632365408315304983105
patients7523654083397293109143182203231
with9983654083516689127
atrial1140365408332547591123138
fibrillation.1293365408317347395111126141173195210248287300
Thromb16083654083337293130188228
Res.18513654083357097111
2014;134(4):783-789.197736540833468100131143173203238258291308320354387421443474507542553
34.4253753085357186
Kaserer5233754083346792126147180200
A,73537540834054
Schedler80137540833163100133172187220241
A,105437540834053
Jetter11193754083245879103135156
A,128737540834053
et135237540833355
al.14193754083314658
Risk14893754083354975103
Factors16043754083326192115151172198
for18143754083185475
Higher‑than‑Expected19013754083435895132166187206227264295332354387419457492523546579618
Residual25303754083356995109147183215229
Rivaroxaban277137540833550811134253854083205786118156189226
Plasma6633854083344980106162194
Concentrations86938540833975113144177214235256288309324361398424
in130538540831552
Real‑Life136938540833569100115136168183202235
Patients.16173854083346586101135172193220233
Thromb18623854083327191127184223
Haemost.209738540834375109166203229251264
2018;118(5):808-817.23733854083346798128140169196227245278295307341375410432467498527532
35.4253953085367186
Sin5243954083324785
CF,6233954083407278
Wong71539540835794132171
KP,9003954083357176
Wong99039540835793132171
TF,11753954083326672
et126139540833456
al.13303954083324861
Plasma14043954083355082109166199
apixaban16163954083327187118151190223261
levels18913954083144982116131157
in206239540831553
Chinese21283954083407893131166193228
patients23693954083397294109144182203231
with26143954083506688127
chronic275439540833169911284254054083385385
kidney5304054083304685123158189
disease‑Relationship7404054083385379114146173208231268303319351372388426464491528543583
with13434054083506689127
renal14904054083215593125141
function16514054083185795127151167205243
and191540540833169108
bleeding20444054083385489125164179217256
complications.232140540833168126165181196228261283298336374401414
Front27564054083325289128149
Pharmacol.42541540833573105126184217249286302315
2022;13:928401.75541540833468101136148178208220255288322358394426435
36.4254253085367288
Hu53342540834482
YF,6354254083356975
Liao7304254083314779117
JN,8674254083247083
Chern97042540834078113134172
CM,116342540834095108
et129142540833457
al.13684254083324760
Identification14484254083155489127149164182199231264285301339377
and184542540833270109
management197442540835890128160199234292327365387
of238142540833757
noncompliance245842540833776114146183241281297311343381414447
in42543540831553
atrial495435408331537490122137
fibrillation649435408317347395111126141173195210248287
patients9534354083387193108143181203230
receiving12004354083215588121136169185223262
dabigatran:147943540833870109125164196218239272310322
the18184354083226095
role19304354083215874109
of205643540833756
a2129435408332
drug21784354083385998137
monitor.233243540835795134149171208230240
Pacing25894354083356799114152191
Clin27974354083405570108
Electrophysiol.4254454083334883115139161198238276307334349387403415
2015;38(4):465-471.85644540833468100130141176210229262279291326362396418454486519528
37.4254553085367079
Schnierer52145540833265103141156190212246267
M,80545540835468
Samoš89045540833265123161188
M,109545540835468
Bolek11804554083357489124155
T1352455408332
et140145540833456
al.14744554083324760
The155145540833372107
Effect16754554083335270105138162
of185445540833756
Proton19274554083355693115152190
Pump213445540833573130170
Inhibitor23214554083145290105145160183219241
Withdrawal25794554083577496134173194227278311326
on42546540833776
Dabigatran51746540834678117133171204226247280318
Etexilate8524654083325387119134149182203237
Plasma11064654083355082108166198
Levels13214654083316598132148174
in151146540831553
Patients15804654083356789104139177199226
With18234654083577496134
Atrial1974465408341628399131146
Fibrillation:21374654083324786108124139154186208223261300312
A2465465408341
Washout252346540835789115153191229252
Study.279246540833253914254754083387080
J520475408325
Cardiovasc5604754083407394132147185217250276309
Pharmacol.88447540833573105126184217249286302315
2020;75(4):333-335.121447540833468101135148181214231264282294329362395417449482515527
38.4254853085367288
Wongcharoen52648540835794132171203241273294332367405
W,94448540835767
Pacharasupa10244854083356799137169190223250287326359
P,139648540833540
Norasetthada144948540834483104137163198221245283315354387
L,184948540833144
et190648540833457
al.19764854083314760
Anti‑Factor204948540834079100115137171201233257294315
Xa237748540833870
Activity24614854083407296111144159182215
of268948540833857
Standard275948540833253861244254954083387091129
and56749540833269108
Japan‑Specific6884954083245695128166188219258293326341358375407
Doses110849540834583110145171
of129249540833757
Rivaroxaban13614954083365183116137174204237276309347
in172049540831553
Thai178649540833271103118
Patients19174954083356788103138176197225
With21554954083577395133
Non‑Valvular230149540834583121143179210225257296311343364
Atrial2678495408340628398130145
Fibrillation.283649540833247425505408339607691106138160175213252265
Circ7055054083405677108
J.82850540832437
2020;84(7):1075-1082.88050540833468101135148183220239274293305335366399432454485516551585598
39.4255153085367184
Martin52251540835487108132147185
AC,7205154083418093
Thomas82551540833372110168200227
W,106551540835766
Mahir114451540835587125140161
Z,131851540833750
et138151540833456
al.14505154083324760
Direct15235154083456081115148172
Oral170751540834769102117
Anticoagulant183751540834179100115147184217256293308340378399
Concentrations224951540834077115147181219240261294316331369407433
in269551540831552
Obese27605154083478712242552540832661
and49952540833169108
High6205254083445997135
Body76852540833573113145
Weight92552540835891106144182203
Patients:11415254083356788104138176197225237
A1391525408341
Cohort144552540833976115153174198
Study.16565254083335491130162172
Thromb18415254083327192129187226
Haemost.208052540834476111168207233256269
2021;121(2):224-233.236252540833468101132140170200231246280297309344379410433464498531544
40.4255353085367490
Speed53653540833372108144184
V,74153540833645
Green80753540834465100136174
B,100253540833649
Roberts107253540833574114150172197225
LN,13175354083327891
et142953540833457
al.15065354083324861
Fixed15885354083334879114154
dose176353540833877104139
rivaroxaban19235354083213770103124162193226266299338
can228153540833265104
be240553540833975
used250153540833864100140
in266253540831453
extremes2735535408335679111314842554540835792119
of56454540833857
bodyweight:64154540833978117149203237252291329351364
A1025545408341
population108654540833978117156171203225240278317
pharmacokinetic142354540833877109130189221253290321337375410433448480
analysis.192354540833270102117149176191217231
J2174545408324
Thromb22185454083337293130189228
Haemost.246654540834476111169208234257271
2020;275754540833468101135148
18(9):2296-2307.4255554083346584117135147182217251286310340375410442449
41.4255653085366981
Piran5275654083355071104142
S,69056540833245
Traquair7555654083335083122160192208229
H,100456540834457
Chan108256540834078110148
N,125056540834558
et132956540833456
al.14055654083324861
Peak148656540833569101131
plasma16375654083395587114172204
concentration186256540833168106139172211232254287309324362401
of228356540833757
direct23605654083385375109142166
oral25465654083375992108
anticoagulants267456540833270921071391762094255754083387691123161183210
in65257540831553
obese72257540833777112139174
patients9135754083397293109143182203231
weighing116157540835085100139177192230269
over144757540833769103124
12015885754083346498
kilograms:17035754083304661100139160193251278290
A2010575408341
retrospective2068575408321557798136162201237269294309341376
study.24615754083264987126158168
Res26465754083357097
Pract27605754083355689121145
Thromb4255854083337293130188228
Haemost.66858540834476111169208234257271
2018;2(4):684-688.95458540833468100131143178196229246258293329365388425461496510
42.4255953085367086
Kim52959540833551109
JH,6565954083246982
Shelat75659540833270105120153174
N,94859540834558
Ji102459540832439
CS.10815954083407487
Apixaban11865954083418095127159198231269
and147359540833270109
Rivaroxaban16005954083355183116138175205238277310348
Anti‑Xa196659540834179101116138175207
Concentration219159540834077115147181219241262295317332370409
Utilization2618595408343668196111140174196211249287
in42560540831553
Clinical4936054083405570108123155188203
Practice.7116054083365689121145161193226239
J965605408324
Cardiovasc10046054083407394132148186218250277309
Pharmacol.132960540833572104126184216249285301314
2023;165960540833468101136147
81(2):165-170.18216054083346681115133145175206240262293322355368
43.4256153085367186
Sennesael52461540833267105143178205238273289
AL,8266154083407286
Larock9256154083316586123156186
AS,11246154083407487
Hainaut12246154083447792129162199222
P,145961540833539
et151161540833456
al.15806154083324860
The165361540833372107
Impact177361540831573112145177201
of198761540833756
Strong20566154083335475112151190
Inducers22596154083145291129161194216243
on251561540833775
Direct26036154083466182116149173
Oral278961540834769102117
Anticoagulant42562540834179101116148185218257295310342380402
Levels.8426254083316598132148174187
Am104562540834199
J1159625408324
Med.119862540835590129143
2021;134(10):1295-1299.135662540833468101132141171201236256287319337349379409443477499530560594629640
44.4256353085357387
Škorňová5256354083326197118155193224256
I,79363540831426
Samoš83163540833264120158184
M,102763540835366
Bolek11056354083357287121150
T,126763540833241
et132063540833355
al.13876354083314658
Does145763540834482117143
atorvastatin16126354083315288109142174200222254275290327
therapy19516354083215892113145183213
change21766354083316899136174208
the23966354083215892
anti‑Xa25006354083316889104125161192
activity27046354083326386101132148169202
in42564540831451
xabans‑treated4896454083296199131168194214236257290321342375414
patients9156454083387091106140177198225
with11526454083496486124
atrial1288645408331527388119134
fibrillation?1434645408317337192107122136168189204241278302
Pharmacol174864540833571103123180212243279295
Res20556454083356995
Perspect.21626454083346788114152187219242255
2021;24296454083346799130137
9(3):e00730.25786454083345385102113147182217249282316328
45.4256553085367186
Camporese52765540834073131170209230264291326
G,86965540834357
Bernardi9416554083367192131163184222238
D,119465540834556
Bernardi12666554083357092130163184222237
E,151965540833245
et158065540833456
al.16526554083324760
Absence172865540834080107142180212246
of198965540833757
interaction20616554083155374108129162195219234272310
between23876554083397496150184219258
rivaroxaban,2660655408321366910212316019122342566540833972110122
tacrolimus5626654083225587108145161176234272298
and87566540833270109
everolimus99966540833466100122159175190247285311
in132566540831553
renal13936654083215593125140
transplant15496654083214376114140179195227265287
recipients18516654083205487102141157191230251279
with21456654083506688127
deep228766540833873108147
vein24496654083326681119
thrombosis25836654083226081118177216255281296322
or42567540833759
atrial499675408332547591123138
fibrillation.652675408317347395111126141173195210248286300
Vascul9676754083366793126163179
Pharmacol.116167540833573105126185217249286302315
2020;130:106682.149167540833468101135148178208243256286317353388424457470
46.4256853085367489
Perlman5296854083356990106163196234
A,77768540834156
Hochberg‑Klein84768540834483115153193228249287310346363398413451
S,131368540833245
Choshen137368540834077116142180215253
Cohen164168540834077116151189
L,184468540833245
et190468540833456
al.19756854083324760
Management205068540835587125157196231289324362384
strategies24496854083264970103125159198214248275
of273968540833756
the28106854083226095
interaction4256954083155374108129162194218234272310
between7496954083397597150184220258
direct10216954083385475109141165
oral12016954083375992107
anticoagulant13226954083327092107139176209248286301333371393
and172969540833270109
drug‑metabolizing18526954083385998137159218253275308347386402417446462499538
enzyme240569540833472101135194229
inducers.26486954083155392129161195216244257
J425705408324
Thromb4647054083337293131189228
Thrombolysis.7077054083337293131189228267283315342356383396
2019;47(4):590-595.111970540833468100130143177209226259276288323356391415449481516527
47.4257153085367079
Suwa51971540833270121154
M,68871540835468
Morii77171540835493114130145
I,93171540831527
Kino9737154083355290128
M.111671540835468
Rivaroxaban11997154083365184117138175205238277310348
or156271540833759
Apixaban16367154083418096127160199232270
for19217154083185677
Non‑Valvular201371540834583122144180211227259298313345366
Atrial2394715408341628499131147
Fibrillation25567154083324786108123139154186208223261299
–2870715408335
Efficacy425725408333506886118151183217
and66072540833169108
Safety7867254083336685119141175
of97972540833756
Off‑Label10537254083476887109142176215250266
Under‑Dosing133772540834481121155177196243282309324362401
According175572540834173104141162200215253292
to206572540832259
Plasma21427254083354982108166198
Concentration.235872540834077115148181219241262295317332370409422
Circ27987254083405576107
J.42573540832437
2019;83(5):991-999.47773540833468100130143178212230264282294329364397415450485521532
48.4257453085367490
Chang53674540834078111149188
M,74474540835569
Yu83374540833671
Z,92474540833851
Shenker99674540833371106144174209230
A,124774540834155
et132274540833557
al.13997454083324861
Effect14807454083335271106139163
of166374540833857
renal17417454083215593125141
impairment190374540831472111145160181240275313335
on225874540833876
the23557454083226095
pharmacokinetics,247174540833977110131190222254292322339377412425755408322376997110
pharmacodynamics,55075540833977109131189221253290330362401433491506538566579
and114475540833270109
safety12687554083265978113135169
of145275540833757
apixaban.15247554083327186118150189222260274
J1813755408324
Clin18527554083405671108
Pharmacol.197675540833572105126184216249286301314
2016;56(5):637-645.230675540833468100131143178213232265283295331365397415452489522534
49.3047553085367285
Wang31505540835789127166
X,33335540833852
Tirucherai3402554083335071109141179214235268283
G,37035540834457
Marbury37775540835587109148186208242
TC,4036554083337285
et41385540833456
al.4212554083314760
Pharmacokinetics,42895540833573105126185217249286317333371406428444475503516
pharmacodynamics,48235540833877109130189221253290330362400433491506538565578
and54195540833270109
safety3047654083265978113135169
of32316540833757
apixaban3303654083327187118151190223261
in35796540831553
subjects36476540832664103118153186210238
with3900654083516689127
end‑stage40426540833473112134161184217256291
renal4348654083215593125141
disease4504654083385380115146173208
on47286540833775
hemodialysis.48196540833772130169208223255271302329344370384
J521865408325
Clin5258654083405570108
Pharmacol.5382654083357210512630477540835790122159175188
2016;56(5):628-636.32507540833468100131143179213232265284296331364398421458492526540
50.3047853085367287
Frost3148854083325289116139
C,33008540834053
Shenker33668540833371106144174208229
A,36098540834055
Gandhi36778540834376114153191206
MD,389785408354100111
et40218540833456
al.4091854083314760
Evaluation4164854083326497113150182204219257296
of44738540833757
the4543854083216095
effect4651854083345372107139163
of48288540833756
naproxen48978540833870109131168199232271
on51818540833775
the5270854083215994
pharmacokinetics5378854083387710913030479540835788120156186202239274296310342369
and34289540833269107
pharmacodynamics35489540833876108128186217249285324356394425482497528555
of41169540833755
apixaban.4184954083317085115147186218256268
Br44659540833556
J453395408324
Clin4569954083405469106
Pharmacol.46879540833572104124182214245281297309
2014;78(4):877-885.5009954083346798129140172205224256273284319351385403438473506518
51.30471053085367082
Wasan314310540835789115148186
SM,334310540833387101
Feland34571054083336782115153192
N,366210540834558
Grant37341054083436598136158
R,390510540833650
et396810540833457
al.40391054083314760
Validation4112105408336678398136169190206244282
of440810540833757
apixaban44781054083327187118151190223261
anti‑factor47531054083316991106129148181214238275296
Xa506310540833871
assay51471054083325985118149
and531010540833270109
impact543310540831472304711540833972104128
of319011540833857
body326211540833978117149
weight.342611540835185101139177199212
Thromb36541154083327193130188227
Res.38971154083357097110
2019;182:51-55.402311540833468100130143173204237250285316335369401413
52.30471253085367187
Testa31521254083336390113146
S,331612540833346
Prandoni33801254083355689127166204242258
P,365612540833540
Paoletti371412540833567105121156178202218
O,395012540834758
et402712540833356
al.41011254083324760
Direct41801254083456081116148172
oral43711254083375992107
anticoagulant44961254083327092107139176209248285301333371393
plasma49071254083385487113171203
levels’51281254083155082117132158171
striking5317125408327507187117133171210
increase30471354083155385106140172198233
in329613540831553
severe33651354083266193127149183
COVID-19356413540834085121137183207237268
respiratory38481354083205481120136157190211248270304
syndrome41681354083265997136158195253288
patients44721354083397294109144182203231
treated47191354083214377109131164204
with49391354083506688127
antiviral50821354083316991106139154176209224
agents:532213540833271106144165193205
The304714540833372107
Cremona31691454083406195153191230262
experience.344614540833466105141162178213251283316329
J3790145408324
Thromb38291454083337293131189228
Haemost.407214540834577112170208235258271
2020;18(6):1320-1323.435914540833468101135148178209228261279291321351383417441472502535569582
53.30471553085367186
Magnocavallo315215540835487126164202235268299332348363401
M,357215540835568
Bellasi36591554083367186101134160175
A,385315540834155
Mariani392715540835587109124156194209
MV,415515540835591100
et427415540833456
al.43491554083324861
Thromboembolic44291554083327293130188227266302360399438454469501
and494915540833170109
Bleeding50771554083355186121161176214253
Risk53491554083355177107
in547515540831552
Atrial3047165408341628499131147
Fibrillation32101654083324786107123138153186207223261299
Patients35251654083356789104139177198226
with37671654083516689127
Chronic39101654083407799136174189221
Kidney41471654083355290128163195
Disease:43581654083456187122154180215228
Role46021654083357389124
of474216540833757
Anticoagulation481416540834180101116148185218257295310342364380418456
Therapy.528616540833272107128161200231241
J3047175408324
Clin30861754083405671108
Med.321017540835489129142
2020;10(1).336717540833469101135148178210229261276287
54.30471853085367388
Thompson314818540833272110168207234272310
LE,34711854083316478
Davis356118540834678109125151
BH,37251854083358093
Narayan38301854083457798131162195233
R,407618540833549
et413818540833456
al.42071854083324760
Personalizing42801854083356889116154193225240255284300338376
Direct46691854083466182116149173
Oral485518540834668101116
Anticoagulant498418540834179101116148185217256294309341379401
Therapy53981854083327110630471954083215493124
for31851954083185677
a3276195408331
Diverse33211954083456193128149176211
Population:354619540833571111149165197219234272310322
Role38821954083357489124
of402019540833756
Race,409019540833568100134146
Kidney42491954083355290128163195
Function,445719540833369107139163179217255268
Drug473819540834667106145
Interactions,48961954083155375108129162195219234272311337350
and525919540833270109
Pharmacogenetics.538219540833572105126304720540835790122159198233271306329344376404417
Clin34792054083405670108
Pharmacol360320540833572105126184217249286302
Ther.392020540833272107128138
2023;113(3):585-599.407420540833468101135147177205235253286303315351385419441475507542553
55.30472153085367286
Hinojar31552154083456099137153186207
R,338321540833650
Jiménez‑Natcher34542154083254098134173208238260307340362394432468489
JJ,39642154083254961
Fernández‑Golfín40462154083336789128161200239275305327374413430449466504
C,457121540834054
et464521540833558
al.47232154083324861
New480521540834581133
oral49592154083375993109
anticoagulants:50892154083327092108140178211251289305337376398426439
a3047225408332
practical30942254083396093126150165197230245
guide33542254083397691130165
for35342254083195678
physicians.362722540833977108135150182197229267293307
Eur39492254083336991
Heart405522540834479111132157
J4227225408324
Cardiovasc42662254083407394133148186218251277309
Pharmacother.459122540833572105126184217249286307346381402412
2015;1(2):134-145.501922540833468100130140170186219237249279309344367398429462474
56.30472353085367288
Pradaxa31562354083355689128161192225
–3402235408335
Souhrn345723540833371110148169208
údajů368523540833877109125162
o3868235408337
přípravdu.39252354083396176116137170202241278291
[cit.4237235408319496486100
2023–06–05].435723540833569102137173210246284322356375387
Available476523540834172105120135168207223258
from:50432354083194178137149
WWW:5213235408357118179191
https://www.ema.europa.eu/en/documents/product‑information/pradaxa‑epar‑product­542423540833860843047245408339667910612617823228529633139042343647150953156860864165569072875578782585188792695999710551091112911511179120512431265130213421380141214371457147315111530156815901649168217041719175717961823186018821916195519882019205320752112215121852206222622662288232623662404243624602480
‑information_cs.pdf3047255408321377594131153211244265281319357394427455469508548567
57.30472653085367180
Rota31452654083357496128
E,329126540833346
Testa33552654083326390113146
L,351926540833145
Di358226540834561
Brigida36612654083355672111126165197
G,387626540834457
et395126540833456
al.40252654083324760
The410326540833372107
management422826540835790128160199234292327365386
of463226540833857
patients47072654083387193109143181203231
with49552654083516789127
acute510026540833264102124158
ischemic52762654083154173111146204219251
stroke30472754083264971108139173
while323327540835089104119154
on340027540833776
direct34892754083385374108141165
oral36672754083375992107
anticoagulants37872754083327092107139176209248286301333371393420
(DOACs):422027540831965113153192220237249
data44822754083387092125
from46202754083184078136
an476927540833270
Italian4852275408315377085100132170
cohort503527540833168107145167191
and523927540833270109
a5361275408332
proposed54062754083396198304728540833977104139179
algorithm.32412854083324786124146162184222280293
J3550285408324
Thromb35892854083337293130189228
Thrombolysis.38322854083337293130188228267282314341356382396
2020;50(3):732-738.424328540833468101135148183217237271288300333367400420451486520533
58.30472953085367288
Limdi315329540833147104144159
NA,332929540834586100
Beasley344729540833570102129144179210
TM,367529540833288101
Sun379329540833370108
J,391929540832436
et397229540833457
al.40462954083324760
Thromboembolic41242954083327293130188227266302360399438454469501
and464229540833270109
Hemorrhagic476929540834479137175197218257289328343375
Outcomes516229540834785108138175234269295
in547529540831553
the30473054083226095
Direct31603054083466182116149173
Oral335230540834768101117
Anticoagulant348730540834179101116148185218257295310342380402
Trials3907305408333506698113139
Across40653054083417293131157184
the42673054083226095
Spectrum438130540833271107139163185223281
of468030540833857
Kidney47553054083355291129164195
Function.496930540833268106139163178216254268
Clin52553054083405570108
Pharmacol538230540833572104126304731540835790122159175
Ther.323731540833372107128138
2021;109(6):1593-1605.339131540833468101132141171202237256290308320349379412445466497528564598610
59.30473253085367184
Chatterjee314932540834078110132156190211227262297
S,346332540833346
Sardar35263254083326587125157178
P,372132540833640
Giri3778325408344608196
JS,38923254083245669
et397832540833456
al.40523254083314760
Treatment41293254083335084116137196231269290
discontinuations44373254083385379111148187208223261299331353368406445471
with49253254083516689127
new506932540833873124
oral52103254083385992108
agents533532540833271106144165193
for30473354083185678
long‑term31413354083155391130153175209230288
anticoagulation:34463354083316991106138175208247285300332354369407446458
insights3920335408315537994133171192220
from41563354083184178136
a4308335408332
meta‑analysis435633540835893115148170203241273288320347362388
of476033540833857
18483333540833465
randomized49143354083215492131169228243272306345
trials5276335408321435890106132
including5424335408315538530473454083155291107144183
101,80132463454083346597106142178209
patients.34713454083387193109143181203231244
Mayo373034540835587118156
Clin39013454083405570108
Proc.40243454083365693126139
2014;89(7):896-907.417934540833468100131143178212231266286297332367402425460496529535
60.30473553085377590
Eliquis31593554083334964104143158185
–3365355408336
Souhrn342235540833373112151173212
údajů365535540833878111127166
o3842355408338
přípravku.39013554083396278118140174206238277291
[cit.4213355408319506588102
2023–06–30].433735540833469103139176214251290323358377389
Available474835540834173106122138171211228263
from:50333554083184179139152
WWW:5206355408358120182195
https://www.ema.europa.eu/en/documents/product‑information/eliquis‑epar‑product­5422355408338618630473654083396780108129181236291302338397431445480519541580620654668704743770802842868905944978101710761112115211741202122912681290132813691408144114661486150315421561160016221682171617381754179318331859189219081924196420022018204520672104214521792200222122622284232323632402243524602480
‑information_cs.pdf3047375408321377594131153211244265281319357394427455469508548567
61.30473853085366981
Reilly31433854083357085101116148
PA,33063854083357286
Lehr340738540833166104125
T,354738540833241
Haertter360338540834477112133158182216237
S,385538540833245
et391538540833456
al.39863854083324760
The406138540833372107
effect41833854083345473107140164
of436238540833756
dabigatran443338540833871110126164197218240273311
plasma47593854083385487113171203
concentrations497738540833168107139172211232254287308324362400426
and541838540833270109
patient30473954083397293109143181203
characteristics326739540833270102123156188212246267283309332348380407
on369239540833775
the37853954083216095
frequency38973954083184075114152187225257290
of420539540833756
ischemic42793954083144073111146204219251
stroke45473954083264971108139173
and473739540833270109
major486339540835890106144165
bleeding50463954083385489124164179217256
in531939540831553
atrial5389395408332547591123138
fibrillation3047405408317347394110125140173194210248286
patients:33494054083387193109143181203231243
The360840540833272107
RE‑LY37304054083367091124155
trial3901405408322435991106
(Randomized40234054083185487125164202260276305339378
Evaluation44174054083336497113150183204220258296
of472940540833756
Long‑Term480140540833269107146169199230251309
Anticoagulation512640540834179101116148185218257295310342364379304741540833776
Therapy).313841540833372107128161200232250261
J3414415408324
Am345341540834199
Coll35684154083407793108
Cardiol.36914154083407394132147185201214
2014;63(4):321-328.392041540833469100131143179213231264281293328361392411443476510523
62.30474253085367187
Halvorsen31484254083447692124162183211246284
S,344642540833245
Atar35054254083416295116
D,363542540834556
Yang370542540833564102141
H,386042540834457
et393142540833456
al.40014254083324760
Efficacy4075425408333506886118151183217
and430542540833270109
safety44284254083265978113135169
of461142540833756
apixaban46814254083327187118150190222261
compared495542540833268127166199220254294
with52624254083516789127
warfarin5403425408351831053047435408318527389126
according31944354083326495132153191207245284
to349843540832259
age357743540833271106
for37034354083195678
stroke38014354083265071108139173
prevention39944354083396195127161200221236274313
in432743540831553
atrial4400435408332547591123138
fibrillation:4559435408317347394110125140172194210248286298
Observations487843540834786113148169204237259274312351377
from52754354083194178137
the54324354083226095
ARISTOTLE30474454083417793125159206238271304
trial.3366445408322435991106119
Eur35014454083326990
Heart360644540834479111132157
J.377844540832537
2014;35(28):1864-1872.383044540833469100131143178211229263297315327356387423459482513544577611624
63.30474553085367287
Xue315445540833874109
QL.32834554083477993
The339645540833372107
frailty3523455408318407388104126160
syndrome:37034554083265897136157195253288300
definition40234554083397391108146161183199237275
and431845540833270109
natural44474554083377092129151184199
history.46664554083385379102139160194204
Clin48904554083405670108
Geriatr501845540834480101116148170192
Med.523045540835489129142
2011;539245540833468100128136
27(1):1-15.30474654083346783115130141171190221251263
64.30474753085367388
Committee314847540834076134191206228252285320
for34804754083195677
Medicinal357047540835488127142174188226258273
Products38554754083355592131168200224251
for41184754083195677
Human420747540834481139171208
Use.442847540834368103115
Reflection45554754083357087104138170194209247284
paper485247540833871109145165
on503047540833775
physical511747540833977107134148180212227
frailty:5357475408318397287102124157170
instruments30474854083155379102123162220255293314342
for34044854083195678
baseline34974854083397298133149164202237
characterisation374948540833169102123156188212246267283309342364379417455
of422048540833756
older42924854083375392127148
populations445548540833978117155171203225240278316343
in481348540831553
clinical4881485408331466199114146179195
trials5091485408322435991106132
[Internet].5238485408319357394128149188223245262274
65.30474953085367286
Cruz‑Jentoft31494954083406199128150171206245266303322347
AJ,35114954083416880
Baeyens360749540833568103134169207233
JP,38554954083246065
Bauer393549540833568106141162
JM,41124954083247993
et422049540833456
al.42914954083324760
Sarcopenia:43664954083336687118155194230268283315327
European47084954083337091128168203235273
consensus499649540833168107133168206232270296
on530749540833776
definition539849540833873901073047505408338537590128167
and322950540833169109
diagnosis:33525054083385486125163201228242269281
Report364850540833570110148170195
of385750540833857
the39295054083226095
European40395054083326990127167202234272
Working432650540835794115146162200239
Group458050540834466103141180
on477550540833776
Sarcopenia48655054083336687118155195230268283315
in519550540831553
Older526350540834763102136158
People.54365054083356830475154083377793128140
Age320251540834179114
Ageing.333251540834079114129167206219
2010;39(4):412-423.356651540833468100132144179213232265282294329359389409446478513526
66.30475253085367389
Park31535254083356788119
CS,32895254083407486
Choi339352540833977116131
EK,35415254083336882
Kim364052540833552109
HM,3766525408345100113
et389652540833456
al.39695254083324860
Increased40475254083145284106140172198233273
risk4337525408320366292
of444652540833757
major452052540835789105143164
bleeding47025254083385489124164179217256
in497552540831553
underweight504552540833775114149170223258273312350371
patients54335254083397230475354083223772110131159
with32215354083516789127
atrial3364535408331537590122138
fibrillation3517535408317347395110125140173194210248286
who381953540835089127
were396153540835185107141
prescribed41175354083396094121153175190229265305
non‑vitamin443753540833876114137169185208240298313351
K4804535408335
antagonist48545354083327091124163201240255281304
oral51745354083375891107
anticoagulants.5296535408332709210713917620930475454083387691123161183210224
Heart328654540834480111133157
Rhythm.345854540833674105130168226239
2017;14(4):501-507.371254540833468100130139170201220253270282318352384402436470503509
67.30475553085367079
Topinková314055540833366106121159189227259291
E,344455540833346
Berková35035554083357091122159191224
M,374055540835468
Mádlová382155540835487126141179211244
P,407855540833539
et413055540833456
al.41995554083324760
„Krátká42725554083215779112134164197
baterie44825554083397294127148164199
pro46945554083386097
testování48045554083215582105142174207244259
fyzické5076555408319538499131161195
zdatnosti52845554083286799120159197223304756540832237
seniorů“31005654083266199114152174212232
a3348565408332
její3396565408315506580
využití349256540833266104133149171187
pro36955654083386097
diagnózu38085654083385385124162201229267
geriatrické40915654083387394110142164185201233263297
křehkosti44045654083295286124154191218241257
v4677565408331
klinické4724565408330466199114146176210
praxi.49505654083396194125141154
Geriatrie512056540834379100116148169191206241
a5377565408332
Gerontologie54255654083447930475754083215896118155171209248264298
2013;2(1):43-49.336157540833468100130141176193225239251286318340377410421
68.30475853085367389
Verrest31495854083356889111144171194
L,335658540833144
Wilthagen34135854083577388110148180219253291
EA,37175854083327589
Beijnen38185854083367085100138173211
JH,40415854083246981
et413558540833456
al.42045854083314759
Influence4276585408315527087124158196228261
of455058540833756
Malnutrition461958540835486102139176199220235258273310349
on498058540833776
the50685854083226094
Pharmacokinetics51755854083357210412518321524728431433030475954083387395110142170
of323159540833857
Drugs330259540834667106145171
Used348759540834470105144
in364659540831552
the37135954083226095
Treatment38225954083335084116138196231269291
of412759540833757
Poverty‑Related419859540833572104138160184218240277312328360382415455
Diseases:46675954083466187122154181216243255
A4937595408341
Systematic49925954083336290113146204237258274306
Review.531259540833671103119153204215
Clin30476054083405570108
Pharmacokinet.317060540833573105126185217249286317333371406428442
2021;60(9):1149-1169.362760540833468101133141177212232264282294324351382416439470498529563574
69.30476153085367285
Andrade314961540834179118139172211246
J,341261540832436
Khairy346561540833574107122143177
P,365961540833539
Dobrev371561540834584124145179212
D3943615408346
et400561540833457
al.40786154083324861
The415561540833372107
clinical4279615408331476199114146179195
profile44906154083396198116133148183
and468961540833270109
pathophysiology48156154083397293132170209248279306320358374412452484
of531661540833756
atrial5389615408332547591123138
fibrillation:3047625408317347395111126142174196211250289301
relationships33686254083215671104126141180218245283298338365
among375362540833290129168207
clinical39816254083314762100115147181196
features,41986254083185385107145167201228241
epidemiology,44606254083347489129164222237276292330370402412
and489362540833270109
mechanisms.502362540835893126164197235251277335362375
Circ54196254083405577108
Res.30476354083357097111
2014;114(9):1453-1468.317363540833468100131143173201232251284302314344375407440462493524560596609
70.30476453085367186
Zhao314764540833876108146
Y,330764540833543
Guo336464540834381119
M,349764540835468
Li357864540833247
D,363964540834556
et370864540833457
al.37786454083324760
Pharmacokinetics385264540833572105126184217249286316333371406428443475503
and436864540833270109
Dosing449164540834584110125163202
Regimens470764540833570109125182217255282
of500264540833857
Direct50726454083466182116149173
Oral525964540834768101117
Anticoagulants538964540834179101116304765540833168101140178193225263285313
in337365540831553
Morbidly343965540835593115154170209224256
Obese370865540834787123150185
Patients:39066554083356789104139177199226239
An415865540834180
Updated425165540834483122155176210250
Literature45146554083324770103125158179217238272
Review.480065540833570103118153204215
Clin50296554083405570108
Appl515065540834181120136
Thromb53006554083327193130188227
Hemost.304766540834479137175202225239
2023;29:10760296231153638.330166540833468101136147182216229259291323355391424458493526561592620650683717751785799
71.30476753085367183
Russo31436754083357399126164
V,332067540833644
Cattaneo33776754083407395119152190225263
D,365367540834656
Giannetti37226754083446091129167202225249264
L,399967540833145
et405767540833456
al.41266754083324760
Pharmacokinetics419967540833573105126184217249286316333370405428443475502
of471467540833857
Direct47846754083456182116148172
Oral496967540834769102117
Anticoagulants509967540834179101116148185218257294310342380401429
in304768540831553
Patients31156854083356789104139177198226
With33566854083587496134
Atrial3506685408341628399131146
Fibrillation36686854083324786108123138154186207223261299
and398368540833169108
Extreme41076854083326589111145203238
Obesity.436068540834787122149164186220230
Clin46066854083395570107
Ther.472968540833272107128138
2021;488268540833569102133141
43(9):e255-e263.50396854083346684117135147181216251283305341376410443456
72.30476953085367288
Martin314969540835487108133148186
KA,33496954083357993
Beyer‑Westendorf345669540833671102137158178235269295319352390429468489511
J,398169540832436
Davidson403169540834577109125164190228267
BL,43126954083356781
et440769540833456
al.44776954083324760
Use455169540834470105
of467069540833756
direct47406954083395475109142166
oral49206954083375992107
anticoagulants50416954083327091107139176208248285300333371392420
in547569540831553
patients30477054083397293109143181203231
with32917054083516789127
obesity343270540833777112139154176210
for36567054083185677
treatment37477054083224377109131189224262284
and404470540833270109
prevention41677054083396094127161199220236274312
of449370540833756
venous456370540833266104142181207
thromboembolism:47847054083215980118176215254290348387426441456483540552
Updated53507054083448312215530477154083225595
communication316171540833168126184222260275307339361377414453
from36337154083184077136
the37877154083226095
ISTH39017154083154781127
SSC404771540833265105
Subcommittee417171540833270109142179237295310332357390426
on461571540833876
Control471071540834077115137158195211
of494071540833757
Anticoagulation.501571540834180101116148185218257295310342364380418456469
J5503715408324
Thromb30477254083337293130188228
Haemost.329072540834476111169208234257271
2021;19(8):1874-1882.357672540833468101133141171201220254272284314345378408431462493528562574
73.30477353085367186
Malá‑Ládová314673540835486101133155188221260297329362
K,352073540833549
Voříšková35827354083357192107135164201233265
E,386073540833345
Košťálová39187354083357298121153168206238270
B,420173540833547
et426173540833456
al.43297354083324760
Terminologie44017354083336384142157194232247285324339373
adherence478773540833270108142163197235266300
k5099735408330
léčbě51417354083155082120155
–5309735408335
prvotní53567354083396094131153304774540833853
konsenzuální311574540832967105132167205234272305320358373
překlad35037454083396094125141173212
pomocí373174540833877136174207222
Delphi39687454083458196135174189
metody.417274540835793115152191223233
Vnitř44217454083357288110131
Lék.45687454083316595110
2022;68(E-2):22-28.469374540833569102136149184220239272293324342354389424444475509522
Další46037635011061108131169193
literatura481476350110244779125158204236287320366
u51997635011051
autora5269763501104597129179212258
a41207735011046
na4184773501105298
www.casopisvnitrnilekarstvi.cz430177350110671372082272673143524034574805185656186416737057587818048528989459781016104910971121114311841226